Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dan Schaber"'
Autor:
Matthew Dimond, Mona Fiuzat, Mitchell A. Psotka, Christopher M. O’Connor, Heart Failure Collaboratory-Academic Research Consortium, William T. Abraham, Tariq Ahmad, Stefan D. Anker, Michael G. Felker, Gerasimos Filippatos, Dalane W. Kitzman, Eric Leifer, Eldrin F. Lewis, JoAnn Lindenfeld, Robert John Mentz, Richard Nkulikiyinka, Dan Schaber, Abhinav Sharma, Scott D. Solomon, Norman Stockbridge, John R. Teerlink, David J. Whellan, Janet T. Wittes
Publikováno v:
Journal of the American College of Cardiology. 79:256
Autor:
Philip G. Jones, Yuanyuan Tang, Michael R. Gold, J. Claude Daubert, Suzanne V. Arnold, Dan Schaber, Anthony Tang, Lou Sherfesee, Michael E. Nassif, William T. Abraham, Cecilia Linde, James B. Young, John A. Spertus, John G.F. Cleland
Background: Clinical trials have established the average benefit of cardiac resynchronization therapy (CRT), but estimating benefit for individual patients remains difficult because of the heterogeneity in treatment response. Accordingly, we created
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d71a928a3df773bb93bb5759c15b76b
http://hdl.handle.net/10044/1/55314
http://hdl.handle.net/10044/1/55314
Autor:
Dan Schaber
Publikováno v:
Journal of the American College of Cardiology. 54:2203-2204
In his commentary in the May 26, 2009, issue of the Journal , Sanderson ([1][1]) makes assertions about the design and implementation of the PROSPECT (Predictors of Response to CRT) trial as well as the role of the sponsor, Medtronic, that require cl